Literature DB >> 26436080

Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis.

Zahra Tolou-Ghamari1, Vahid Shygannejad2, Fereshteh Ashtari2, Ahmad Chitsaz2, Abbas Ali Palizban3.   

Abstract

BACKGROUND: Previous publications reported that an individual's month of birth (MOB) might have an important correlation to that consequent risk of multiple sclerosis (MS). AIM: The aim of this preliminary study was to investigate the distribution of different MOBs inpatients with MS in Isfahan, Iran.
MATERIALS AND METHODS: This investigation was conducted to the Isfahan Neurosciences Research Centre. 1283 patients with MS were studied. Clinical data were recorded in d-Base and analyzed using SPSS (version 18) for Windows.
RESULTS: Of the total population studied there were 979 females and 304 males. The mean age of all the patients was 34.6 years (range 10-87 years). Within the total population, the MOBs in the 62% of patients were in the season's spring and summer, and in 38% of patients they were in the season's autumn and winter. As the MOB might be recognized to have a bearing on an individual's risk of contracting MS, the highest and lowest correlations seem to be linked with April, September, May (↑), and November (↓), respectively.
CONCLUSIONS: The seasonal relationship between MOBs and MS risk might be pointed toward a potential function for vitamin D throughout pregnancy or the early life of the newborn. Further studies are needed to confirm these correlations.

Entities:  

Keywords:  Iranian population; month of birth; multiple sclerosis; spring

Year:  2015        PMID: 26436080      PMCID: PMC4581128          DOI: 10.4103/2277-9175.162543

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


INTRODUCTION

Multiple sclerosis (MS) is a recurrent tentative disease of the central nervous system (CNS) that typically follows a deteriorating course, with accumulation of plaques associated with the demyelination of axons and the loss of oligodendrocytes. It is hypothesized that the loss of axons is the main mechanism underlying progressive disability. Escalating data suggest there are two main types of risk factors for MS, genetic and environmental, likely with complex interactions between them and effects that may be harmful or protective, depending on the patient.[123] Month of birth (MOB) has formerly been expressed as a risk question for MS. Torkildsen et al., presented an update regarding the MOB as a risk factor for MS. The outcome appears to be mainly important in high-risk regions for the disease, particularly in districts with low sunlight exposure. No MOB effects or insignificant correlation in districts with high sunshine exposure have been reported.[4] Disanto et al., documented that the risk of different immune-mediated diseases in the UK might be considerably prejudiced by the season of birth, suggesting the effect of gestational ultraviolet B and vitamin D exposure.[5] The association of spring birth with the risk of MS has been confirmed by Saastamoinen et al.[6] Studies related to the association between MOB and MS incidence in Southern Iran recognized that the outcomes are comparable to those detailed by many earlier studies.[7] It has also been documented that in the nonexistence of sufficient control for confusing features such as year and place of birth, the previous report for the involvement of MS with MOB might possibly include false positives.[8] Regarding Latin America and Portugal, a recent study showed the nonexistence of a seasonality model relating the risk of MS to MOB.[9] Another study related the risk of MS in different latitudes of South America to MOB showed that MS patients born to mothers who were pregnant at different southern latitudes do not follow the seasonal pattern observed at higher northern latitudes.[10] The Isfahan MS Society (IMSS) reported a period prevalence of 73.3/100,000 between April 2003 and July 2010, and an incidence rate of 9.1/100,000 in the year 2009. A recent study confirmed a prevalence of 93.6for Isfahan, Iran.[11121314] The aim of this study was to investigate the distribution of MOB in patients with MS in Isfahan, Iran.

MATERIALS AND METHODS

A retrospective study was performed on 1283 patients with MS, those attended MS clinic located at the Isfahan Kashani Hospital. The study was conducted to the Isfahan Neurosciences Research Centre (INRC). Demographic and clinical data together with the date of birth including MOB, gender, and age were recorded in d-Base. The statistical analysis of the data was performed using SPSS (version 18) for Windows.

RESULTS

Figure 1 shows that 76% of the total population studied were females (n = 979) and 24% were males (n = 304). The mean age of all patients was 34.6 years (range10-87 years). Figure 2 shows that the age of 87% of patients ranged 20-49 years. Figure 3 shows the distribution of patients according to MOBs. The highest and lowest associations could be linked to April and November, respectively. The MOBs in 62% (n = 609) of patients were in spring-summer and in 38% (n = 370) were in autumn-winter.
Figure 1

Fraction of gender in population studied (n=1283)

Figure 2

Distribution of age in population studied (n=1283)

Figure 3

Distribution of patients according to month of birth

Fraction of gender in population studied (n=1283) Distribution of age in population studied (n=1283) Distribution of patients according to month of birth A further analysis related to gender showed that in the male population (n = 304), the MOBs in 59% were in spring-summer and in 41% (n = 124) were in autumn-winter [Figure 4].
Figure 4

Distribution of (a) females and (b) males according to their month of birth

Distribution of (a) females and (b) males according to their month of birth The mean age of male patients was 36.9 years (range 14-85 years). The mean age of females was 33.9 years (range 10-87 years). In the females the highest population of MS (62%) was linked to spring-summer as follows: September (n = 137), April (n = 127), and May (n = 125).

DISCUSSION

The result of this preliminary analysis of MOB in patients with MS in Isfahan, Iran is in agreement with previous publications,[715] as the MOB with the highest population of MS was ranked in spring months such as April and May. Previous publications reported that Isfahan could be considered as an area with a medium to high risk of MS.[311121314] Furthermore, the results of this survey also supported that the highest rate of patient population could be linked to the age group of 20-39 (67%), followed by 30-39 (36%), and 40-49 (22%) years. This is in agreement with earlier publications that reported an increasing incidence of MS within the younger population, which results in a major economic burden on the patient, their family, the health system, and society.[16171819] In the present study, the MOBs in 62% of patients were in September, April, and May. Numerous investigations have pointed toward MOBs as an indicator of the risk feature for MS susceptibility and disease progression. Previous publication reported also a higher risk of MS for those born in April (ratio 1.07, P = 0.002) and May (ratio 1.11, P = 0.0006), and a lower risk for those born in October (ratio 0.94, P = 0.004) and November (ratio 0.88, P = 0.0002).[15] The seasonal association between MOB and the risk of MS might be explained by the relationship between geographic latitude and risk, as the effect appears to be most important in high-risk regions, particularly in regions with low ultraviolet light exposure and low maternal vitamin D levels. Exposure to sunlight during pregnancy or early childhood might be associated with the risk of MS, as low exposure could mean a lower amount of vitamin D.[202122] Finally, in order to move further toward the prediction of: (1) Prevention aspects in the first important step (2) therapeutic and pharmacotherapy management in the second step additional advance studies, to analyze many features from maternity to maturity and the environmental geographies that are coupled with susceptibility to MS are recommended in Isfahan, Iran.
  22 in total

1.  Time of birth, residential solar radiation and age at onset of multiple sclerosis.

Authors:  Tzu-Yun McDowell; Sania Amr; Patricia Langenberg; Walter Royal; Christopher Bever; William J Culpepper; Douglas D Bradham
Journal:  Neuroepidemiology       Date:  2010-03-18       Impact factor: 3.282

2.  Month of birth is not a definite risk factor for multiple sclerosis.

Authors:  Maria José Sá
Journal:  Arq Neuropsiquiatr       Date:  2014-05       Impact factor: 1.420

3.  Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland.

Authors:  Kari-Pekka Saastamoinen; Marja-Kaisa Auvinen; Pentti J Tienari
Journal:  Mult Scler       Date:  2011-10-31       Impact factor: 6.312

4.  HLA-DRB1 and month of birth in multiple sclerosis.

Authors:  S V Ramagopalan; J Link; J K Byrnes; D A Dyment; G Giovannoni; R Q Hintzen; E Sundqvist; I Kockum; C Smestad; B A Lie; H F Harbo; L Padyukov; L Alfredsson; T Olsson; A D Sadovnick; J Hillert; G C Ebers
Journal:  Neurology       Date:  2009-12-15       Impact factor: 9.910

Review 5.  [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis].

Authors:  Satoru Ohji; Kyoichi Nomura
Journal:  Nihon Rinsho       Date:  2008-06

6.  Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.

Authors:  Yára Dadalti Fragoso; Tarso Adoni; Sandra Maria Garcia de Almeida; Soniza Vieira Alves-Leon; Walter Oleschko Arruda; Fiorella Barbagelata-Aguero; Joseph Bruno Bidin Brooks; Adriana Carra; Rinaldo Claudino; Elizabeth Regina Comini-Frota; Eber Castro Correa; Alfredo Damasceno; Benito Pereira Damasceno; Ethel Ciampi Díaz; David George Elliff; Ana Patrícia Peres Fiore; Clelia Maria Ribeiro Franco; Maria Cristina Brandao Giacomo; Sidney Gomes; Marcus Vinicius Magno Gonçalves; Anderson Kuntz Grzesiuk; Jose Luiz Inojosa; Damacio Ramón Kaimen-Maciel; Katia Lin; Josiane Lopes; Gisele Alexandre Lourenço; Alejandra Diana Martínez; Mario Oscar Melcon; Nívea de Macedo Oliveira Morales; Rogério Rizo Morales; Marcos Moreira; Shirlene Vianna Moreira; Celso Luis da Silva Oliveira; Francisco Tomaz Menezes de Oliveira; João Batista Ribeiro; Sonia Beatriz Felix Ribeiro; Claudia Cárcamo Rodríguez; Liliana Russo; Juliana Safanelli; Kirsty Deborah Shearer; Fabio Siquineli; Darwin Vizcarra-Escobar
Journal:  Arq Neuropsiquiatr       Date:  2013-09       Impact factor: 1.420

Review 7.  The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.

Authors:  Ruth Dobson; Gavin Giovannoni; Sreeram Ramagopalan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-14       Impact factor: 10.154

8.  Confounding underlies the apparent month of birth effect in multiple sclerosis.

Authors:  Barnaby Fiddes; James Wason; Anu Kemppinen; Maria Ban; Alastair Compston; Stephen Sawcer
Journal:  Ann Neurol       Date:  2013-07-02       Impact factor: 10.422

9.  Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.

Authors:  Zahra Tolou-Ghamari; Vahid Shaygannejad; Fereshteh Ashtari
Journal:  Int J Prev Med       Date:  2013-05

10.  What is the Real Fate of Vitamin D in Multiple Sclerosis?

Authors:  Vahid Shaygannejad; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05
View more
  4 in total

Review 1.  A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis.

Authors:  Matin Khosravi-Largani; Parmida Pourvali-Talatappeh; Ali Mohammad Rousta; Maedeh Karimi-Kivi; Elahe Noroozi; Ali Mahjoob; Yasaman Asaadi; Alireza Shahmohammadi; Sarina Sadeghi; Shiva Shakeri; Kimiya Ghiyasvand; Masoumeh Tavakoli-Yaraki
Journal:  eNeurologicalSci       Date:  2018-01-28

2.  Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D3.

Authors:  Natalia Niedziela; Krystyna Pierzchała; Jolanta Zalejska-Fiolka; Jacek T Niedziela; Ewa Romuk; Magdalena Torbus-Paluszczak; Monika Adamczyk-Sowa
Journal:  Biomed Res Int       Date:  2018-08-23       Impact factor: 3.411

3.  Vitamin D in early life and later risk of multiple sclerosis-A systematic review, meta-analysis.

Authors:  Kamila Ismailova; Pratiksha Poudel; Alexandr Parlesak; Peder Frederiksen; Berit L Heitmann
Journal:  PLoS One       Date:  2019-08-27       Impact factor: 3.240

Review 4.  Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.

Authors:  Masoud Amiri
Journal:  J Clin Transl Res       Date:  2021-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.